Zobrazeno 1 - 10
of 16
pro vyhledávání: '"JINGFANG JU"'
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-5 (2018)
Abstract Despite tremendous research efforts focused on diagnosis and treatment, pancreatic ductal adenocarcinoma remains the third leading cause of cancer-related death in the United States, with a 5-year overall survival rate of less than 5%. Altho
Externí odkaz:
https://doaj.org/article/9746b089130c48b1b4f8ded13bae65c4
Autor:
Yaguang Xi, Andrea Formentini, Minchen Chien, David B. Weir, James J. Russo, Jingyue Ju, Marko Kornmann, Jingfang Ju
Publikováno v:
Biomarker Insights, Vol 1, Pp 113-121 (2006)
The functions of non-coding microRNAs (miRNAs) in tumorigenesis are just beginning to emerge. Previous studies from our laboratory have identifi ed a number of miRNAs that were deregulated in colon cancer cell lines due to the deletion of the p53 tum
Externí odkaz:
https://doaj.org/article/4d8c1d4148324cf3904f3daa9ee4f398
Autor:
Xiao Zheng, Yuanyuan Fu, Juan Liu, Changping Wu, Yaoyu Ying, Yun Ding, Jingting Jiang, Jingfang Ju, Wei Wei
Publikováno v:
Translational Cancer Research
Background B7-H7 is a newly identified member of the B7 immune checkpoint family, but has not been investigated in epithelial ovarian cancer (EOC). This study aimed to determine the B7-H7 expression profile and its potential clinical significance in
Autor:
Apisri Leamniramit, Song Wu, Andrew Fesler, Dongling Ma, Wenzhe Li, Jie Yang, Jingfang Ju, Haiyan Zhai
Publikováno v:
Oncotarget
// Jie Yang 4, * , Dongling Ma 2, * , Andrew Fesler 1, * , Haiyan Zhai 1 , Apisri Leamniramit 2 , Wenzhe Li 2 , Song Wu 3 and Jingfang Ju 1 1 Translational Research Laboratory, Department of Pathology, Stony Brook University, Stony Brook, NY 11794, U
Autor:
Wenya, Su, Wenlu, Xiao, Lujun, Chen, Qi, Zhou, Xiao, Zheng, Jingfang, Ju, Jingting, Jiang, Zhigang, Wang
Publikováno v:
OncoTargets and therapy
Background IFIT2 (interferon-induced proteins with tetratricopeptide repeats 2), also known as ISG54, is an important interferon-stimulated gene family protein, which has been confirmed to play a crucial role in anti-cancer as well as anti-virus proc
Autor:
Bing Ni, Hao Wu, Yin Tian, Zhiping Zhao, Songsong Liu, Jingfang Ju, Huaizhi Wang, Li Yin, Shixiang Guo, Jianjun Li, Yongsheng Ouyang, Wenhua Li, Z Tian, Xuejun Xu
Publikováno v:
Oncogene
The aberrant expression of microRNAs (miRNAs) has emerged as an important hallmark of cancer. However, the molecular mechanisms underlying the changes in miRNA expression remain unclear. In this study, we discovered a novel epigenetic mechanism of mi
Autor:
Wenwei Hu, Jingting Jiang, Xiao Zheng, Anthony Tong, Stephanie Burke, Andrew Fesler, Qi Wang, Lujun Chen, Xiao-Dong Li, Jingfang Ju, Changping Wu, Bin Xu
Publikováno v:
Oncotarget
B-cell specific moloney leukemia virus insertion site 1 (Bmi-1) gene plays important roles in gastric cancer, but the epigenetic regulatory mechanism by microRNA (miRNA) and the functional significance of Bmi-1 inhibition in gastric cancer remains el
Autor:
Jingfang Ju
Publikováno v:
Bioanalysis. 2:901-906
Since the discovery of noncoding small miRNAs and their function in controlling mRNA translational rate, the small non-coding miRNA world has become a research wonderland for cancer and other human diseases. Due to the critical regulatory function, m
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 4, p e35158 (2012)
PLoS ONE, Vol 7, Iss 4, p e35158 (2012)
Purpose microRNAs have emerged as key regulators of gene expression, and their altered expression has been associated with tumorigenesis and tumor progression. Thus, microRNAs have potential as both cancer biomarkers and/or potential novel therapeuti
Autor:
Jingfang Ju, Haiyan Zhai
Publikováno v:
Frontiers in Genetics
Frontiers in Genetics, Vol 2 (2011)
Frontiers in Genetics, Vol 2 (2011)
MicroRNAs (miRNAs) are a class of non-coding small RNAs with critical regulatory functions as post-transcriptional regulators. Due to the fundamental importance and broad impact of miRNAs on multiple genes and pathways, dysregulated miRNAs have been